Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism

An Epidemic of Redundant Meta‐analyses

(2021) Céline Chapelle et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer

(2021) Gary H. Lyman et al.   Blood Advances

Incidental venous thromboembolism, detected by chance, but still venous thromboembolism

(2020) Guy Meyer et al.   EUROPEAN RESPIRATORY JOURNAL

Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer

(2020) Giancarlo Agnelli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Direct Oral Anticoagulants for the Treatment of Acute Venous Thromboembolism Associated with Cancer: A Systematic Review and Meta-Analysis

(2020) Michela Giustozzi et al.   THROMBOSIS AND HAEMOSTASIS

Accuracy of the Ottawa score in risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism. A systematic review and meta-analysis.

(2019) Aurélien Delluc et al.   HAEMATOLOGICA

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update

(2019) Nigel S. Key et al.   JOURNAL OF CLINICAL ONCOLOGY

Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial

(2019) Robert D. McBane et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)

(2018) Annie M. Young et al.   JOURNAL OF CLINICAL ONCOLOGY

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

(2018) Gary E. Raskob et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study

(2018) Marcello Di Nisio et al.   THROMBOSIS AND HAEMOSTASIS

Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials

(2014) Martin H Prins et al.   Lancet Haematology

Development of a Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism in Patients With Cancer-Associated Venous Thromboembolism

(2012) Martha L. Louzada et al.   CIRCULATION

Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

Oral Rivaroxaban for Symptomatic Venous Thromboembolism

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

(2009) Sam Schulman et al.   NEW ENGLAND JOURNAL OF MEDICINE